LXO Group hybrid capital acquisition financing
We advised Hayfin Capital Management on its hybrid capital investment in LXO Group
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Penumbra $14.5 billion sale to Boston Scientific
We are advising Penumbra on the transaction
W. L. Gore & Associates acquisition of Conformal Medical
We are advising Gore on the transaction
LifeScan emerges from chapter 11
We advised an ad hoc group of secured lenders in connection with LifeScan’s chapter 11 proceedings
Novo Nordisk proposed $9.1 billion acquisition of Metsera
We are advising Novo Nordisk on the transaction
Amulet Capital Partners sale of SSI Strategy to Clinigen
We are advising Amulet Capital Partners and SSI Strategy on the sale
Strive acquisition of Semler Scientific
We are advising Strive on the acquisition
UST sale of HealthProof to Bain
We advised UST on the transaction
Adagene $25 million strategic equity investment from Sanofi
We advised Adagene on the transaction
Charles River Laboratories cooperation agreement with Elliott
We are advising Charles River on the agreement